Abnormalities in the metabolic pathways of catecholamines may provide information for better diagnosis and treatment of depression. The numerous alternatives for pathways of degradation of NE can alter the amounts of DHPG, MHPG, and VMA that are produced. These biochemical markers may help to predict which drugs will be effective.

---